Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

10.07 +0.41 (+4.24%)
Streaming Delayed Price Updated: 3:41 PM EDT, Mar 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 Next >
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Add Erin L. Russell to Board of Directors
Fortrea and Starboard enter into Cooperation Agreement 
From Fortrea Holdings Inc
Via GlobeNewswire
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
Fortrea to Sponsor SCRS’ Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical Trials 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Fortrea to Present at the Citi Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the Evercore HealthCONx Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reports Third Quarter 2024 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Releases Inaugural Corporate Social Responsibility Report
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fortrea Holdings Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fortrea Holdings Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Fortrea Reports Second Quarter 2024 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Appoints Robert Parks as Chief Accounting Officer
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the Jefferies Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Appoints Machelle Sanders to Board of Directors
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reports First Quarter 2024 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients 
From Fortrea Holdings Inc
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.